Skip to main content
Premium Trial:

Request an Annual Quote

DNAnexus, SolveBio Ink Product Integration Agreement

NEW YORK (GenomeWeb) – DNAnexus and SolveBio have agreed to integrate their respective platforms to provide customers with more seamless access to curated biomedical data and cloud-based data management and analysis tools.

According to the companies, the combined solution will help customers like pharmaceutical and biotechnology companies, sequencing services providers, and diagnostics developers move quickly from genomic data analysis to interpretation. Clients will also have access to new discoveries and expert assessments of the genomics space that could help them make decisions about research and development investments and treatment plans, the partners said. Customers will be able to integrate this information into their existing workflows and pipelines in a standardized manner.

The partnership will "help remove barriers to genomic insight and provide better solutions to enterprises globally," DNAnexus CEO Richard Daly said in a statement.

"Our goals are aligned with those of DNAnexus and an integration between our solutions makes a great deal of sense," SolveBio CEO Mark Kaganovich added. "We look forward to our collective customers being able to seamlessly integrate their analyses with the contextual information that SolveBio provides."

Financial and other terms of the agreement were not disclosed.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.